Development Level

Tbio 10 | 11,445
Tchem 2 | 1,598
Tclin 1 | 613

IMPC Phenotype

increased circulating sodium l... 2 | 71
abnormal behavior 1 | 298
abnormal behavioral response t... 1 | 66
abnormal sleep behavior 1 | 70
cardiovascular system phenotyp... 1 | 36
decreased circulating glucose ... 1 | 126
decreased circulating iron lev... 1 | 32
decreased grip strength 1 | 116
decreased leukocyte cell numbe... 1 | 73
decreased mean corpuscular vol... 1 | 79
decreased prepulse inhibition 1 | 82
decreased red blood cell distr... 1 | 41
hyperactivity 1 | 148
hypoactivity 1 | 132
impaired righting response 1 | 26
improved glucose tolerance 1 | 79
increased circulating alanine ... 1 | 13
increased circulating potassiu... 1 | 29
increased erythrocyte cell num... 1 | 39
increased hematocrit 1 | 46
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 96
increased vertical activity 1 | 24
shortened PQ interval 1 | 7
shortened RR interval 1 | 17

Disease

Carcinoma 11 | 11,493
pancreatic ductal adenocarcinoma liver metastasis 9 | 1,962
lung cancer 8 | 4,740
non-small cell lung cancer 8 | 2,890
ovarian cancer 8 | 8,520
Autosomal recessive predisposition 7 | 1,442
Immunologic Deficiency Syndromes 7 | 113
psoriasis 7 | 6,694
intraductal papillary-mucinous adenoma (IPMA) 6 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 6 | 2,989
lung adenocarcinoma 6 | 2,716
lung carcinoma 6 | 2,843
Age related macular degeneration 5 | 72
Complement deficiency 5 | 14
Kidney cancer 5 | 2,613
Kidney disease 5 | 430
Melanoma 5 | 711
Meningitis 5 | 67
Skin cancer 5 | 469
adrenocortical carcinoma 5 | 1,428
colon cancer 5 | 1,478
invasive ductal carcinoma 5 | 2,951
malignant mesothelioma 5 | 3,232
Astrocytoma, Pilocytic 4 | 3,081
Duchenne muscular dystrophy 4 | 601
Hemolytic-Uremic Syndrome 4 | 30
Liver Cirrhosis, Experimental 4 | 769
Macular degeneration 4 | 65
Anemia 3 | 365
Atopic dermatitis 3 | 952
Atypical Hemolytic Uremic Syndrome 3 | 9
Complement deficiency disease 3 | 6
Increased susceptibility to bacterial infections 3 | 42
Neisseriaceae Infections 3 | 3
Prone to bacterial infection 3 | 42
Recurrent bacterial infection 3 | 42
Rheumatoid arthritis 3 | 1,191
breast carcinoma 3 | 1,638
cystic fibrosis 3 | 1,696
diabetes mellitus 3 | 1,728
glioblastoma 3 | 5,792
group 3 medulloblastoma 3 | 4,104
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
limb girdle muscular dystrophy 2A 3 | 213
osteosarcoma 3 | 7,950
tuberculosis 3 | 2,010
Becker muscular dystrophy 2 | 191
C8 deficiency 2 | 2
Cancer 2 | 2,499
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 2 | 7
Increased susceptibility to Neisseria meningitidis infections 2 | 4
Kuhnt-Junius degeneration 2 | 14
Liver cancer 2 | 604
Lupus Erythematosus, Systemic 2 | 67
Meningitis, Meningococcal 2 | 3
Meningococcal Infections 2 | 4
Meningococcal meningitis 2 | 8
Myasthenia gravis 2 | 23
Paroxysmal nocturnal hemoglobinuria 2 | 10
Peritonitis 2 | 43
Pneumonia 2 | 174
Systemic lupus erythematosus 2 | 194
Thrombocytopenia 2 | 197
atypical teratoid / rhabdoid tumor 2 | 5,112
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 510
chronic lymphosyte leukemia 2 | 204
dermatomyositis 2 | 966
ductal carcinoma in situ 2 | 1,745
fibroadenoma 2 | 559
head and neck cancer and chronic obstructive pulmonary disease 2 | 239
interstitial cystitis 2 | 2,312
juvenile dermatomyositis 2 | 1,187
medulloblastoma, large-cell 2 | 6,241
mucosa-associated lymphoid tissue lymphoma 2 | 484
non diabetic and post-ischemic heart failure 2 | 200
pancreatic cancer 2 | 2,398
pituitary cancer 2 | 1,972
primary Sjogren syndrome 2 | 735
Alopecia areata 1 | 41
Alport syndrome 1 | 21
Ascariasis 1 | 7
Chronic Kidney Diseases 1 | 13
Congenital afibrinogenemia 1 | 11
Doyne honeycomb retinal dystrophy 1 | 9
Glomerulonephritis 1 | 46
Hematuria 1 | 36
Henoch-Schoenlein purpura 1 | 12
Hypermobility syndrome 1 | 17
Infarction, Middle Cerebral Artery 1 | 33
Lyme disease 1 | 26
Macular Degeneration, Age-Related, 1 1 | 9
Nephrotic Syndrome 1 | 78
Ovarian Cysts 1 | 41
Ovarian serous cystadenocarcinoma 1 | 5
Progressive renal failure 1 | 13
Pulmonary Fibrosis 1 | 106
Salpingitis 1 | 6
Tetanus 1 | 68
Thickening of glomerular basement membrane 1 | 7
Type 1 diabetes mellitus 1 | 109

Tissue

Liver and Pancreas 13 | 16,750
Urinary Tract 13 | 16,678
Endocrine System 12 | 18,159
Blood and immune system 10 | 16,909
Digestive Tract 10 | 17,369
Female tissues 10 | 17,400
Male tissues 10 | 17,142
Respiratory system 10 | 16,393
Skin and soft tissues 10 | 17,230
Cardiovascular System 9 | 15,192
Nervous System 9 | 16,725

Target Family

Non-IDG 12 | 12,091
Enzyme 1 | 4,145

GO Process

complement activation, alterna... 13 | 13
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Complement C3 C3 Tbio Non-IDG -3.55963 3446.1 1079
Properdin CFP Tbio Non-IDG -3.18478 1522.9 371
Complement factor H CFH Tbio Non-IDG -3.15872 1420.9 593
Complement factor B CFB Tchem Non-IDG -2.85144 694.6 495
Complement factor D CFD Tchem Enzyme -2.41491 244.6 226
Complement C5 C5 Tclin Non-IDG -2.26690 170.8 448
Complement component C9 C9 Tbio Non-IDG -1.88910 74.6 285
Complement component C8 alpha chain C8A Tbio Non-IDG -1.72118 49.8 10
V-set and immunoglobulin domain-containing protein 4 VSIG4 Tbio Non-IDG -1.55121 39.1 140
Complement component C8 beta chain C8B Tbio Non-IDG -1.57123 37.0 104